Abstract
Ubiquitin-specific Peptidase 13 (USP13) is a deubiquitinating enzyme that regulates the stability or function of its substrate. USP13 is highly amplified in human ovarian cancer, and elevated expression of USP13 promotes tumorigenesis and metastasis of ovarian cancer. However, there is little known about USP13 post-translational modifications and their role in ovarian cancer. Here, we found that USP13 is phosphorylated at Thr122 in ovarian cancer cells. Phosphorylated Thr122 (pT122) on endogenous USP13 was observed in most human ovarian cancer cells, and the abundance of this phosphorylation was correlated to the total level of USP13. We further demonstrated that Casein kinase 2 (CK2) directly interacts with and phosphorylates USP13 at Thr122, which promotes the stability of USP13 protein. Finally, we showed that Threonine 122 is important for cell proliferation of ovarian cancer cells. Our findings may reveal a novel regulatory mechanism for USP13, which may lead to novel therapeutic targeting of USP13 in ovarian cancer.
Reference43 articles.
1. (2012). Feature article: Treating the untreatable: A breakthrough in understanding the biology and treatment of ovarian cancer. Exp. Biol. Med., 237, viii.
2. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018
3. Copy number signatures and mutational processes in ovarian carcinoma;Macintyre;Nat. Genet,2018
4. Whole-genome characterization of chemoresistant ovarian cancer;Patch;Nature,2015
5. Breaking the chains: Deubiquitylating enzyme specificity begets function;Clague;Nat. Rev. Mol. Cell Biol.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献